Quarterly report pursuant to Section 13 or 15(d)

Equity (Details)

v3.23.1
Equity (Details) - USD ($)
 1 Months Ended 9 Months Ended
May 02, 2022
Jan. 19, 2023
Mar. 31, 2023
Equity (Details) [Line Items]      
Underwritten public offering   12,545,454  
Common stock price to public per share (in Dollars per share)   $ 2.75  
Underwritten offering of common stock, issued   1,636,363  
Gross proceeds (in Dollars)   $ 34,500,000  
Offering expenses (in Dollars)   2,500,000  
Net proceeds (in Dollars)   $ 32,000,000  
Weighted average fair value grant date (in Dollars per share)     $ 1.96
Equity incentive plan [Member]      
Equity (Details) [Line Items]      
Shares of common stock     280
Restricted stock units     420,000
Weighted average fair value grant date (in Dollars per share)     $ 7.6
Employee Stock Purchase Plan [Member]      
Equity (Details) [Line Items]      
Vesting period     3 years
Minimum [Member]      
Equity (Details) [Line Items]      
Vesting period     4 years
Vesting percentage     0.00%
Maximum [Member]      
Equity (Details) [Line Items]      
Vesting period     5 years
Vesting percentage     200.00%
ATM Sales Agreement [Member]      
Equity (Details) [Line Items]      
Aggregate offering price (in Dollars) $ 50,000,000    
Restricted Stock Units [Member]      
Equity (Details) [Line Items]      
Restricted stock units     2,000,000
Weighted average fair value grant date (in Dollars per share)     $ 3.21